Seropositive rheumatoid arthritis affecting multiple joints simultaneously, confirmed by positive rheumatoid factor, with no documented involvement of organs or organ systems beyond the musculoskeletal system.
Verified May 8, 2026 · 8 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 10
- Region
- Multi-region
Documentation tips
What should appear in the chart to support M05.79.
Source · Editorial brief grounded in 8 cited references ↓
- Document explicit positive RF or anti-CCP lab values with the result, reference range, and date — without serology confirmation in the record, the M05 family cannot be defended on audit.
- Name each affected joint in the clinical note (e.g., bilateral wrists, MCPs, knees) to substantiate 'multiple sites'; a vague 'polyarticular RA' without joint enumeration invites a downcode to M06.90.
- Explicitly state that no organ or system involvement is present — or is not currently active — to lock in the 'without organ/systems involvement' qualifier and avoid migration to M05.1–M05.5.
- Record disease activity level (remission, low, moderate, high) using a validated tool such as DAS28 or CDAI; payers and risk-adjustment models flag encounters lacking activity documentation.
- If the patient is on a biologic or DMARD, document the medication name, dose, and response — this supports medical necessity and HCC risk-adjustment capture.
Related CPT procedures
Procedure codes commonly billed with M05.79. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M05.79 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Assigning M05.79 when RF status is not documented: serology must be confirmed positive in the record; absent results require M06.09 (seronegative, multiple sites) or M06.90 (unspecified).
- Using M05.79 when extra-articular organ involvement is documented: pulmonary, cardiac, or vasculitic manifestations push the correct code into the M05.1–M05.5 subcategories, not M05.7x.
- Defaulting to M05.79 instead of a site-specific M05.7x code when only one joint region is affected — multiple sites means multiple distinct anatomic regions are actively involved in the same encounter.
- Conflating seropositivity with organ involvement: a positive RF alone does not create organ involvement; the provider must explicitly document a systemic complication to justify moving out of M05.79.
- Failing to update the code when disease status changes — if a patient previously coded as M05.79 develops interstitial lung disease, the code set must be updated to reflect the organ involvement subcategory.
Clinical context
Source · Editorial summary grounded in 8 cited references ↓
M05.79 is the go-to code when a patient carries a confirmed positive rheumatoid factor (RF) or anti-CCP result and presents with polyarticular disease — meaning more than one joint region is actively involved — and the treating provider has not documented extra-articular organ or system complications such as pulmonary, cardiac, or vasculitic manifestations. This is a seropositive, multi-site code within the M05.7 parent subcategory, which covers RF-positive RA without organ/system involvement.
The key branching decisions at claim time: Is the patient RF-positive (M05 family) or seronegative (M06 family)? Is joint involvement single-site with documented laterality (use the numbered site-specific codes under M05.7) or genuinely multi-site (M05.79)? If RF status is undocumented, drop to M06.90. If organ or system involvement is documented — pulmonary nodules, pericarditis, vasculitis, Felty syndrome — move to the appropriate M05.1–M05.5 subcategory instead.
M05.79 groups into MS-DRG v43.0 clusters 545 (with MCC), 546 (with CC), and 547 (without CC/MCC), so accurate comorbidity capture alongside this code directly affects DRG assignment and reimbursement. In an orthopedic setting, this code commonly appears alongside surgical and injection procedures when polyarticular RA drives the encounter.
Sibling codes
Other billable codes under M05.7 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 8 cited references ↓
01What lab results are required to use M05.79 instead of M06.09?
02How many joints must be involved to justify 'multiple sites'?
03Can M05.79 be used when the patient has osteoporosis or anemia secondary to RA?
04What is the difference between M05.79 and M05.9?
05Does M05.79 require a 7th character?
06If organ involvement develops mid-year, should the coder update M05.79 to an M05.1–M05.5 code?
07Which DRGs does M05.79 map to?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective Oct 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M05-M14/M05-/M05.79
- 03icdcodes.aihttps://icdcodes.ai/diagnosis/rheumatoid-arthritis-involving-multiple-sites/documentation
- 04icdcodes.aihttps://icdcodes.ai/diagnosis/seropositive-rheumatoid-arthritis/documentation
- 05pmc.ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC7560310/
- 06aapc.comhttps://www.aapc.com/codes/icd-10-codes/M05.79
- 07healthcareinspiredllc.comhttps://healthcareinspiredllc.com/rheumatoid-arthritis-factor-or-not/
- 08allzonems.comhttps://www.allzonems.com/blogs/icd-10-musculoskeletal-coding-guide/
Mira AI Scribe
The Mira AI Scribe captures RF and anti-CCP lab values, each affected joint by name, disease activity score, current DMARD or biologic regimen, and an explicit provider statement that no organ or system involvement is present. This prevents audit downcodes to M06.90 (unspecified serostatus), missed HCC risk-adjustment capture, and payer denials tied to missing serology documentation.
See how Mira captures M05.79 documentation